APRE Stock Analysis: Buy, Sell, or Hold?
APRE - Aprea Therapeutics, Inc. Common stock
$0.80
0.21 (34.92%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 24, 2026
Get Alerted When APRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called APRE this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: APRE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: APRE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: APRE is currently trading at $0.80, which is considered oversold relative to its 30-day fair value range of $0.80 to $0.95.
Technical Outlook: Technically, APRE is in a strong downtrend. Immediate support is located at $0.55, while resistance sits at $1.49. The stock is showing strong short-term momentum, up 34.9% recently.
Market Sentiment: APRE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.00 (+779.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, APRE is in a strong downtrend. Immediate support is located at $0.55, while resistance sits at $1.49. The stock is showing strong short-term momentum, up 34.9% recently.
Market Sentiment: APRE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.00 (+779.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.80 -
$0.95
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
57.9%
Protect Your Profits
Holding APRE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Strong upward momentum (+34.9%)
- BULLISH: Trading 779.4% below Wall St target ($7.00)
Fair Price Analysis
30-Day Fair Range
$0.80 -
$0.95
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.55
Resistance Level
$1.49
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.93
Wall Street Target
$7.00
(+779.4%)
Revenue Growth (YoY)
-99.5%
Last updated: January 31, 2026 9:15 PM ET
Data refreshes hourly during market hours. Next update: 10:15 PM
Data refreshes hourly during market hours. Next update: 10:15 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
Advanced APRE Option Strategies
Professional options setups generated by AI based on today's APRE price and gamma walls.
